Prothena Corporation plc
General ticker "PRTA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $559.2M (TTM average)
Prothena Corporation plc follows the US Stock Market performance with the rate: 0.6%.
Estimated limits based on current volatility of 3.5%: low 10.55$, high 11.32$
Factors to consider:
- Total employees count: 163 (-5.8%) as of 2024
- Top business risk factors: Climate change and natural disasters, Cybersecurity threats, Third-party risks, Intellectual property risks, Pandemic risks
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [8.25$, 20.65$]
- 2025-12-31 to 2026-12-31 estimated range: [8.80$, 21.12$]
Financial Metrics affecting the PRTA estimates:
- Negative: with PPE of -6.5 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -18.81 <= 0.33
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Negative: negative Industry operating cash flow (median)
- Positive: Shareholder equity ratio, % of 89.00 > 63.39
- Negative: negative Net income
- Negative: -0.15 < Industry inventory ratio change (median), % of 0
- Positive: Inventory ratio change, % of -6.15 <= -0.75
Short-term PRTA quotes
Long-term PRTA plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $53.91MM | $91.37MM | $135.16MM |
| Operating Expenses | $185.46MM | $282.41MM | $289.72MM |
| Operating Income | $-131.56MM | $-191.04MM | $-154.56MM |
| Non-Operating Income | $5.95MM | $30.56MM | $25.63MM |
| R&D Expense | $135.56MM | $220.57MM | $222.52MM |
| Income(Loss) | $-125.61MM | $-160.48MM | $-128.93MM |
| Taxes | $-8.66MM | $-13.45MM | $-6.62MM |
| Profit(Loss)* | $-116.95MM | $-147.03MM | $-122.31MM |
| Stockholders Equity | $622.04MM | $561.37MM | $486.93MM |
| Assets | $758.03MM | $696.38MM | $547.11MM |
| Operating Cash Flow | $-108.82MM | $-133.91MM | $-150.05MM |
| Capital expenditure | $0.46MM | $2.81MM | $0.30MM |
| Investing Cash Flow | $-0.46MM | $-2.77MM | $-0.30MM |
| Financing Cash Flow | $241.46MM | $45.10MM | $1.55MM |
| Earnings Per Share** | $-2.47 | $-2.76 | $-2.27 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.